Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
14 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Lamivudine Teva Pharma B.V.“
Suchtreffer
Begriffe & Kennungen
Lamivudine Teva Pharma B.V. · 4.8 · Cases of osteonecrosis have been reported, particularly in patients with generally acknowledged risk factors,
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Gastrointestinal disorders Common: Nausea, vomiting, abdominal pain or cramps, diarrhoea. Rare: Pancreatitis,
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · General disorders and administration site conditions Common: Fatigue, malaise, fever.
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Hepatobiliary disorders Uncommon: Transient elevations in liver enzymes (AST, ALT). Rare: Hepatitis.
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · In HIV-infected patients with severe immune deficiency at the time of initiation of combination antiretroviral
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Metabolism and nutrition disorders Very rare: Lactic acidosis.
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Musculoskeletal and connective tissue disorders Common: Arthralgia, muscle disorders. Rare: Rhabdomyolysis.
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Paediatric population 1206 HIV-infected paediatric patients aged 3 months to 17 years were enrolled in the ARR
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Respiratory, thoracic and mediastinal disorders Common: Cough, nasal symptoms.
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Skin and subcutaneous tissue disorders Common: Rash, alopecia. Rare: Angioedema.
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · The adverse reactions considered at least possibly related to the treatment are listed below by body system, o
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · The following adverse reactions have been reported during therapy for HIV disease with lamivudine:
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Weight and levels of blood lipids and glucose may increase during antiretroviral therapy (see section 4.4)
Eintrag öffnen